Key result
A combined approach of intensive lipid management, omega-3 fatty acids, and vitamin D3 supplementation reduced coronary calcium scores in 44% of asymptomatic adults over a mean of 18 months.
Why the study?
Does a combined therapeutic approach of intensive lipid management, omega-3 fatty acid, and vitamin D3 supplementation reduce coronary calcium scores in asymptomatic adults with CCS ≥ 50?
Cohort (n=45)
Open-label
Does a combined therapeutic approach of intensive lipid management, omega-3 fatty acid, and vitamin D3 supplementation reduce coronary calcium scores in asymptomatic adults with CCS ≥ 50?
A combined approach of intensive lipid lowering, omega-3 fatty acids, and vitamin D3 supplementation may reduce or slow the progression of coronary calcium scores in asymptomatic adults.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in asymptomatic adults; leaves open whether combined therapy slows progression in randomized trials.
The impact of intensive lipid management, omega-3 fatty acid, and vitamin D3 supplementation on atherosclerotic plaque was assessed through serial computed tomography coronary calcium scoring (CCS). Low-density lipoprotein cholesterol reduction with statin therapy has not been shown to reduce or slow progression of serial CCS in several recent studies, casting doubt on the usefulness of this approach for tracking atherosclerotic progression. In an open-label study, 45 male and female subjects with CCS of > or = 50 without symptoms of heart disease were treated with statin therapy, niacin, and omega-3 fatty acid supplementation to achieve low-density lipoprotein cholesterol and triglycerides < or = 60 mg/dL; high-density lipoprotein > or = 60 mg/dL; and vitamin D3 supplementation to achieve serum levels of > or = 50 ng/mL 25(OH) vitamin D, in addition to diet advice. Lipid profiles of subjects were significantly changed as follows: total cholesterol -24%, low-density lipoprotein -41%; triglycerides -42%, high-density lipoprotein +19%, and mean serum 25(OH) vitamin D levels +83%. After a mean of 18 months, 20 subjects experienced decrease in CCS with mean change of -14.5% (range 0% to -64%); 22 subjects experienced no change or slow annual rate of CCS increase of +12% (range 1%-29%). Only 3 subjects experienced annual CCS progression exceeding 29% (44%-71%). Despite wide variation in response, substantial reduction of CCS was achieved in 44% of subjects and slowed plaque growth in 49% of the subjects applying a broad treatment program.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2008) conducted a cohort in Asymptomatic coronary atherosclerosis (n=45). Intensive lipid management, omega-3 fatty acid, and vitamin D3 supplementation was evaluated on Change in serial computed tomography coronary calcium scoring (CCS). A combined approach of intensive lipid management, omega-3 fatty acids, and vitamin D3 supplementation reduced coronary calcium scores in 44% of asymptomatic adults over a mean of 18 months.
Synapse has enriched 10 related papers. Consider them for comparative context: